Full-Time

Sr. Mgr. Customs Services & Projects

Posted on 2/2/2025

Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceuticals and vaccines

No salary listed

Senior, Expert

Pointe-Claire, QC, Canada + 2 more

More locations: Mississauga, ON, Canada | Brandon, MB, Canada

The job may require presence in one of the specified Pfizer sites in Belgium or Canada.

Category
Procurement & Sourcing
Quality Control & Compliance
Supply Chain Management
Operations & Logistics
Requirements
  • Bachelor’s Degree in international trade, supply chain logistics or related field and 7 – 10 years of experience of import and / or export, vendor management and other trade compliance operations preferably in a pharmaceutical industry, consultancy services.
  • 5+ years of project management experience, including tracking, planning and implementation projects.
  • Expert knowledge of import and export regulations, customs laws, trade sanctions, embargoes, licensing requirements and trade agreements such as free trade agreements and preferential trade arrangements.
  • Interpersonal skills to influence and spit change, facilitate and enhance performance within a cross functional environment.
  • In-depth knowledge and experience with internal and external regulatory audit programs.
  • Experience with leading, executing and maintaining Compliance programs.
  • Ability to prioritize, quickly synthesize information and apply regulatory requirements to a variety of scenarios.
  • Must exercise excellent judgment, make decisions based on a clear understanding of the regulations, deploying strategies to conduct compliant business.
  • Strong negotiation, communication, and relationship – building skills as well, problem – solving, decision - making and presentation capabilities.
  • Creative, curious and adaptive learner willing to seek out continuous improvement opportunities while minimizing business risk and driving the Company to meet objectives across multiple areas.
Responsibilities
  • Ensure the direction and strategy that allows operational flexibility, efficiencies, and risk mitigation in collaboration with customs service vendors (brokers).
  • Ensure the design and maintenance of a structured, fit-for-purpose framework of vendor governance to ensure effective oversight and management of all customs outsourced activities.
  • Responsible for the regularly reviews total scope of outsourced services from an operational perspective to ensure effective management of resources and identify opportunities for continuous improvement.
  • Research and brings forward industry trends, partnership management, innovation in the field of customs service vendor and best practices beneficial to GLNS organization.
  • Responsible to set goals and objectives for the customs service’s vendor function aligned with GLNS focus areas.
  • Manage and establish appropriate metrics, KPIs and scorecards to measure performance, health of the partnership and achievement of goals and objectives.
  • Collaborates with Global Transportation Solution, Procurement and Global Trade Compliance to establish efficient and effective contracting processes to ensure all vendor contracts are in place achieving GLNS critical milestones.
  • Partners with Global Procurement, Global Transportation Solution and Global Trade Compliance functions the selection and onboarding of new vendors.
  • Operationally ensure service and partnership-level issues resolution.
  • Run the customs projects on a day – to – day basis, making sure that the project produces the required deliverable within the specified constraints of time and cost, and achieve desired results.
  • Serve as a customs and compliance operational expert matter, providing strategic insights and recommendations.
  • Orchestrate at a global level in partnership of key stakeholders’ litigation management process.
  • Advice on the compliance implication of operational decisions. Stay ahead of trends and challenges, proactively advising on potential impacts and opportunities.
  • Identify and assess potential compliance risk related to customs and compliance operational activities, developing strategies to mitigate risk.
  • Lead and mentor customs and compliances operational teams, fostering a strong culture of compliance.
  • Develop and deliver training programs for colleagues on customs and compliance operations, ensuring awareness and understanding across the organization.
  • Establish metrics and reporting mechanism to measure effectiveness of the customs and compliance operations program.
Desired Qualifications
  • Master’s degree.
  • At least 3-5 years in leadership roles. Ability to lead customs operations and compliance team with a leadership approach that energizes, motivates and facilitate teamwork while encouraging innovative ideas, approaches and accountability.
  • SAP GTS Knowledge.
  • Professional trade certifications or similar.
  • PMP certified.
  • Proven track record driving positive change in a complex environment.
  • Demonstrate strong problem – solving skills based on facts, data and understanding of the regulatory requirement in complex and evolving environments; must be able to apply sound risk management.
  • Able to handle organizational complexity and ambiguity.

Pfizer focuses on creating and producing healthcare products, particularly medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold globally. Pfizer's products include vaccines, cancer treatments, and other specialized medications. A key aspect of Pfizer's operations is its collaboration with BioNTech to develop a vaccine for COVID-19, showcasing its role in addressing public health challenges. Unlike many competitors, Pfizer emphasizes not only the development of new drugs but also the distribution of vaccines to underserved communities. The company's goal is to enhance public health by expanding its range of effective treatments and ensuring access to its products worldwide.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Activist investor Starboard Value's $1B stake may drive strategic changes and increase value.
  • Pfizer's investment in Enara Bio strengthens its position in the immunotherapy market.
  • Backing Promise Bio aligns with Pfizer's strategy to enhance its precision medicine portfolio.

What critics are saying

  • Emerging biotech companies like Trimtech and Normunity could impact Pfizer's market share.
  • Slowdown in COVID-19 vaccine demand poses potential revenue challenges for Pfizer.
  • Activist investor involvement may pressure Pfizer to alter business strategies.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • Pfizer invests in AI disease models, enhancing R&D capabilities and drug discovery.
  • Pfizer's focus on precision medicine diversifies its therapeutic areas and strengthens its portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Company News

Finsmes
Mar 5th, 2025
Trimtech Therapeutics Raises $31M in Seed Funding

Trimtech Therapeutics, a Cambridge, UK-based biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, raised $31M in Seed funding

Business Wire
Jan 16th, 2025
Normunity Closes $75 Million Series B Financing to Advance Lead Drug Program Into the Clinic and Broaden Pipeline of Novel Anti-Cancer Therapies Targeting Untapped Drug Mechanisms

Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The

TechCrunch
Oct 23rd, 2024
Promise Bio exits stealth backed by Pfizer and AstraZeneca | TechCrunch

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune diseases.

The Wall Street Journal
Oct 7th, 2024
Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer

The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.

Benzinga
Oct 3rd, 2024
Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens®

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health InvestorsEnara Bio's EDAPT® platform is

INACTIVE